NASDAQ: MLYSMineralys Therapeutics Inc Stock Ownership - Who owns Mineralys Therapeutics?
Insider buying vs selling
Have Mineralys Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jon Congleton | CEO | 2026-09-30 | 75,000 | $25.46 | $1.91MSell |
| Brian Taylor Slingsby | Director | 2026-09-22 | 104,320 | $28.81 | $3.01MSell |
| Eric Warren | CCO | 2026-09-21 | 7,438 | $28.12 | $209.13kSell |
| Eric Warren | CCO | 2026-09-21 | 7,438 | $13.24 | $98.48kBuy |
| Daphne Karydas | Director | 2026-09-15 | 3,000 | $12.02 | $36.06kBuy |
| Daphne Karydas | Director | 2026-09-15 | 3,000 | $28.58 | $85.74kSell |
| Eric Warren | CCO | 2026-08-21 | 7,437 | $25.98 | $193.19kSell |
| Eric Warren | CCO | 2026-08-21 | 7,437 | $13.24 | $98.47kBuy |
| David Malcom Rodman | Med | 2026-08-10 | 2,170 | $27.09 | $58.79kSell |
| David Malcom Rodman | Med | 2026-08-10 | 2,170 | $16.00 | $34.72kBuy |
MLYS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MLYS insiders and whales buy or sell their stock.
MLYS Shareholders
What type of owners hold Mineralys Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Brian Taylor Slingsby | 17.75% | 15,715,756 | $243.59M | Insider |
| Srinivas Akkaraju | 13.71% | 12,140,369 | $188.18M | Insider |
| Samsara Biocapital GP LLC | 12.14% | 10,749,832 | $166.62M | Insider |
| Ra Capital Management LP | 4.22% | 3,734,458 | $57.88M | Insider |
| Hbm Healthcare Investments Cayman Ltd | 3.63% | 3,218,106 | $49.88M | Insider |
| Jon Congleton | 0.60% | 528,621 | $8.19M | Insider |
| James J. Ferguson Iii | 0.12% | 102,400 | $1.59M | Insider |
| David Malcom Rodman | 0.06% | 51,384 | $796.45k | Insider |
| Adam Scott Levy | 0.05% | 48,538 | $752.34k | Insider |
| Eric Warren | 0.04% | 38,400 | $595.20k | Insider |
MLYS vs Biotech Stocks
Mineralys Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.